Oxidative Stress High Impact Factor
An imbalance between the assembly of reactive oxygen
species (ROS) and therefore the
detoxification of their reactive intermediates causes oxidative stress.
Cells must answer this imbalance before the highly reactive
molecules damage cellular structures, particularly DNA. Severe and prolonged
oxidative stress can trigger
apoptosis and necrosis. Numerous pathological conditions have an
oxidative stress component, including
cardiovascular diseases,
neurodegenerative diseases like Alzheimer’s disease, and chronic inflammation. High-impact
journals are those considered to be highly influential in their respective fields. The
impact factor of journal provides quantitative assessment tool for grading, evaluating, sorting and comparing
journals of comparable kind. It reflects the typical number of citations to recent
articles published in science and science
journals during a particular year or period, and is usually used as a proxy for the relative importance of a journal within its field. it's first devised by Eugene Garfield, the founding father of the Institute for Scientific Information. The
impact factor of a journal is evaluated by dividing the amount of current year citations to the source items published therein journal during the previous two years
High Impact List of Articles
-
Mesenchymal stem cells in the reconstruction surgery of the supraspinatus muscle lesions
Petr Smid, Martin Komzak, Radek Hart, Libor Pasa
Research Paper: Clinical Investigation
-
Mesenchymal stem cells in the reconstruction surgery of the supraspinatus muscle lesions
Petr Smid, Martin Komzak, Radek Hart, Libor Pasa
Research Paper: Clinical Investigation
-
A review of randomization methods in clinical trials
Vance W Berger & Olga Antsygina
Clinical Trail Perspective: Clinical Investigation
-
A review of randomization methods in clinical trials
Vance W Berger & Olga Antsygina
Clinical Trail Perspective: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors for the treatment of breast cancer: recent trial data
Thach-Giao Truong, Pamela Munster
Review: Clinical Trail Outcomes: Clinical Investigation
-
Histone deacetylase inhibitors for the treatment of breast cancer: recent trial data
Thach-Giao Truong, Pamela Munster
Review: Clinical Trail Outcomes: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Linagliptin tablets first to receive US FDA approval at one dosage strength for Type 2 diabetes treatment
News and Views: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Src inhibitors in the treatment of metastatic bone disease: rationale and clinical data
Brendan Boyce, Lianping Xing
Review Article: Clinical Investigation
-
Chemoprevention of prostate cancer: is there evidence from clinical trials?
Marcelo Langer Wroclawski, Cynthia Kuk, Antonio Finelli, Neil E Fleshner, Alexandre R Zlotta
Therapeutic Prospective: Clinical Investigation
-
Chemoprevention of prostate cancer: is there evidence from clinical trials?
Marcelo Langer Wroclawski, Cynthia Kuk, Antonio Finelli, Neil E Fleshner, Alexandre R Zlotta
Therapeutic Prospective: Clinical Investigation
Relevant Topics in Clinical